drugset / Trial / NCT01250795
Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to assess the safety, immunogenicity,and tolerability of a H5N1 Vaccine in healthy adults.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HAI-05 | Unknown | 15 ug | Other |
| Subject | HAI-05 | Unknown | 45 ug | Other |
| Subject | HAI-05 | Unknown | 90 ug | Other |
Indications
No indication recorded.